Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 7c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.39), $0.07 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c